Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadaaki Yamada

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
Translational Lung Cancer Research|December 13, 2023
The landscape of immune therapy in vulnerable patients with advanced non-small cell lung cancer: a narrative reviewKenji Morimoto, Tadaaki Yamada, Koichi Takayama
Translational Lung Cancer Research|February 10, 2023
The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative reviewSatomi Morita-Tanaka, Tadaaki Yamada, Koichi Takayama
Clinical Pharmacology in Drug Development|April 13, 2019
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of NaldemedineKazuya Fukumura, Tadaaki Yamada, Takaaki Yokota, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|January 18, 2005
[A case of solitary endobronchial metastasis of prostatic cancer]Tadaaki Yamada, Taichiro Arimoto, Nobuyo Komatani, et al.
Drugs & Aging|February 23, 2020
Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of AgeJames Wild, Lynn Webster, Tadaaki Yamada, et al.
Cancer Science|March 23, 2012
Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsSeiji Yano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Pain Medicine (Malden, Mass.)|April 4, 2017
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainLynn R Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|June 23, 2005
[A case of non-mucin-producing papillary adenocarcinoma with a 19-year clinical history before operation]Isao Hasegawa, Taichiro Arimoto, Tadaaki Yamada, et al.
Pain|May 31, 2019
Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trialsJames Wild, Tadaaki Yamada, Juan Camilo Arjona Ferreira, et al.
Cureus|June 26, 2023
A Case of Takotsubo Cardiomyopathy Triggered by Asthma Exacerbation After mRNA-based Vaccination for COVID-19Yusuke Tachibana, Tadaaki Yamada, Taisuke Tsuji, et al.
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
Translational Lung Cancer Research|December 13, 2023
The landscape of immune therapy in vulnerable patients with advanced non-small cell lung cancer: a narrative reviewKenji Morimoto, Tadaaki Yamada, Koichi Takayama
Translational Lung Cancer Research|February 10, 2023
The landscape of cancer cachexia in advanced non-small cell lung cancer: a narrative reviewSatomi Morita-Tanaka, Tadaaki Yamada, Koichi Takayama
Clinical Pharmacology in Drug Development|April 13, 2019
The Influence of Renal or Hepatic Impairment on the Pharmacokinetics, Safety, and Tolerability of NaldemedineKazuya Fukumura, Tadaaki Yamada, Takaaki Yokota, et al.
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|January 18, 2005
[A case of solitary endobronchial metastasis of prostatic cancer]Tadaaki Yamada, Taichiro Arimoto, Nobuyo Komatani, et al.
Drugs & Aging|February 23, 2020
Safety and Efficacy of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Non-Cancer Pain Receiving Opioid Therapy: A Subgroup Analysis of Patients ≥ 65 Years of AgeJames Wild, Lynn Webster, Tadaaki Yamada, et al.
Cancer Science|March 23, 2012
Ligand-triggered resistance to molecular targeted drugs in lung cancer: roles of hepatocyte growth factor and epidermal growth factor receptor ligandsSeiji Yano, Shinji Takeuchi, Takayuki Nakagawa, et al.
Pain Medicine (Malden, Mass.)|April 4, 2017
A Phase 2b, Randomized, Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients with Chronic Noncancer PainLynn R Webster, Tadaaki Yamada, Juan Camilo Arjona Ferreira
Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|June 23, 2005
[A case of non-mucin-producing papillary adenocarcinoma with a 19-year clinical history before operation]Isao Hasegawa, Taichiro Arimoto, Tadaaki Yamada, et al.
Pain|May 31, 2019
Onset of action of naldemedine in the treatment of opioid-induced constipation in patients with chronic noncancer pain: results from 2 randomized, placebo-controlled, phase 3 trialsJames Wild, Tadaaki Yamada, Juan Camilo Arjona Ferreira, et al.
Cureus|June 26, 2023
A Case of Takotsubo Cardiomyopathy Triggered by Asthma Exacerbation After mRNA-based Vaccination for COVID-19Yusuke Tachibana, Tadaaki Yamada, Taisuke Tsuji, et al.
Pageof 23